In multiple myeloma concentration of angiogenic factors (VEGF, bFGF, and HGF) is higher in bone marrow than in peripheral blood.

被引:0
|
作者
Di Raimondo, F [1 ]
Azzaro, MP [1 ]
Palumbo, GA [1 ]
Bagnato, S [1 ]
Sortino, G [1 ]
Giustolisi, R [1 ]
机构
[1] Univ Catania, Catania, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4551
引用
收藏
页码:297B / 297B
页数:1
相关论文
共 50 条
  • [21] Analysis of clonal immunoglobulin gene rearrangement in peripheral blood and bone marrow of multiple myeloma by PCR-SSCP.
    Wu, SL
    Wang, LH
    Wang, Y
    Xue, HP
    Zhu, P
    [J]. BLOOD, 1995, 86 (10) : 3368 - 3368
  • [22] An update of allogeneic transplantation with peripheral blood stem cells (PBSCT) as compared to bone marrow (BMT) in multiple myeloma
    Gahrton, G
    Apperley, J
    Bacigalupo, A
    Björkstrand, B
    Bladé, J
    Cavo, M
    Cornelissen, J
    De Laurenzi, A
    Facon, T
    Hagman, A
    Ljungman, P
    Michallet, M
    Niederwieser, D
    Powles, R
    Reiffers, J
    Russell, N
    Samson, D
    Schaefer, U
    Schattenberg, A
    Tura, S
    Verdonck, L
    Vernant, J
    Willemze, R
    Volin, L
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 : S13 - S13
  • [23] LONG TERM CULTURE OF BONE-MARROW BIOPSIES AND PERIPHERAL BLOOD LEUCOCYTES FROM PATIENTS WITH MULTIPLE MYELOMA
    NILSSON, K
    [J]. ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION A-PATHOLOGY, 1970, 78 (04): : 492 - &
  • [24] Allogeneic peripheral blood stem cell transplantation (PBSCT) compared to bone marrow transplantation (BMT) in multiple myeloma
    Gahrton, G
    Svensson, H
    Cavo, M
    Apperley, J
    Bacigalupo, A
    Björkstrand, B
    Blade, J
    Cornelisson, J
    de Laurenzi, A
    Facon, T
    Hagman, A
    Ljungman, P
    Michallet, M
    Niederwieser, D
    Powles, R
    Reiffers, J
    Russell, N
    Samson, D
    Schaefer, U
    Schattenberg, A
    Tura, S
    Verdonck, L
    Vernant, J
    Willemze, R
    Volin, L
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S39 - S39
  • [25] High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma
    Steiner, Normann
    Hajek, Roman
    Sevcikova, Sabina
    Borjan, Bojana
    Joehrer, Karin
    Goebel, Georg
    Untergasser, Gerold
    Gunsilius, Eberhard
    [J]. PLOS ONE, 2017, 12 (07):
  • [26] P15 AND DAPK METHYLATION IN MULTIPLE MYELOMA AND MGUS: COMPARISON BETWEEN BONE MARROW AND PERIPHERAL BLOOD
    Geraldes, C.
    Cristina Goncalves, A.
    Alves, R.
    Pais, A.
    Cortesao, E.
    Pereira, M.
    Sousa, I.
    Teixeira, A.
    Nascimento Costa, J.
    Sarmento, An
    [J]. HAEMATOLOGICA, 2013, 98 : 318 - 318
  • [27] Bone marrow IRF4 level in multiple myeloma: an indicator of peripheral blood Th17 and disease
    Bai, Hua
    Wu, Shuang
    Wang, Rong
    Xu, Ji
    Chen, Lijuan
    [J]. ONCOTARGET, 2017, 8 (49) : 85392 - 85400
  • [28] Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications
    GarciaSanz, R
    Gonzalez, M
    Orfao, A
    Moro, MJ
    Hernandez, JM
    Borrego, D
    Carnero, M
    Casanova, F
    Barez, A
    Jimenez, R
    Portero, JA
    SanMiguel, JF
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (01) : 81 - 88
  • [29] Absence of HHV8/KSHV DNA in peripheral blood and bone marrow harvests from patients with multiple myeloma
    Gardiner, N
    Livingstone, W
    Simmonds, P
    Lawler, M
    McCann, SR
    Browne, PV
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 : 24 - 24
  • [30] Expression of the angiogenesis-inducing molecules VEGF and bFGF in multiple myeloma and its regulation by paracrine interactions between tumor cells and stromal bone marrow cells.
    Van Riet, I
    Hellebaut, L
    Castronovo, V
    Vande Broek, I
    Arras, N
    Vanderkerken, K
    Van Camp, B
    [J]. BLOOD, 2000, 96 (11) : 361A - 361A